Edition:
United States

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

6.29USD
18 Aug 2017
Change (% chg)

$0.09 (+1.45%)
Prev Close
$6.20
Open
$6.11
Day's High
$6.39
Day's Low
$6.11
Volume
56,955
Avg. Vol
67,407
52-wk High
$8.97
52-wk Low
$3.55

Select another date:

Wed, Aug 9 2017

BRIEF-Rockwell Medical Q2 loss per share $0.14

* Q2 sales $13.2 million Source text for Eikon: Further company coverage:

BRIEF-Rockwell Medical, Baxter Healthcare settle arbitration

* Rockwell Medical Inc - on June 23, 2017, co and Baxter Healthcare Corporation settled the arbitration related to claims made by each party

Rockwell Medical shareholders back Ravich for board seat-sources

NEW YORK Shareholders of Rockwell Medical Inc. voted investor Mark Ravich onto the company's board of directors, according to people familiar with the matter.

Rockwell Medical shareholders back Ravich for board seat-sources

NEW YORK, June 1 Shareholders of Rockwell Medical Inc. voted investor Mark Ravich onto the company's board of directors, according to people familiar with the matter.

Rockwell Medical loses round in U.S. court in proxy fight

A U.S. judge has rejected Rockwell Medical Inc's request to block two investors who have launched a proxy fight against the biopharmaceuticals company from soliciting shareholder votes ahead of its June 1 annual meeting.

BRIEF-Rockwell Medical says Richmond, Ravich each personally own less than 1 pct of co

* Co "clarifies that David Richmond and Mark Ravich each personally own less than 1% of Rockwell" Source text for Eikon: Further company coverage:

Rockwell Medical loses round in U.S. court in proxy fight

A U.S. judge has rejected Rockwell Medical Inc's request to block two investors who have launched a proxy fight against the biopharmaceuticals company from soliciting shareholder votes ahead of its June 1 annual meeting.

Rockwell Medical loses round in U.S. court in proxy fight

May 25 A U.S. judge has rejected Rockwell Medical Inc's request to block two investors who have launched a proxy fight against the biopharmaceuticals company from soliciting shareholder votes ahead of its June 1 annual meeting.

BRIEF-Glass Lewis supports election of Mark Ravich to Rockwell Medical board

* Glass Lewis supports election of Mark H. Ravich to Rockwell Medical Inc board

BRIEF-Rockwell Medical reports Q1 loss per share $0.09

* Qtrly sales were $14.6 million, or $1.0 million higher than Q1 2016, primarily due to higher domestic sales Source text for Eikon: Further company coverage:

Select another date: